Endo Appoints New President of Branded Pharmaceuticals
August 11, 2016
Endo International plc (Dublin, Ireland) has appointed Joseph J. Ciaffoni as President, U.S. Branded Pharmaceuticals, effective August 15, 2016. Ciaffoni recently served as Senior Vice President, Global Specialty Medicines Group for Biogen, leading the development and execution of all aspects of global strategy across the value chain for marketed and pipeline products. At Biogen Ciaffoni also held senior roles including Senior Vice President, U.S. Commercial and Vice President, U.S. Neurology Field Operations and Marketing. Prior to joining Biogen, Mr. Ciaffoni was Executive Vice President and Chief Operating Officer of Shionogi Inc. and President of Shionogi Pharmaceuticals.
Is Artificial Intelligence a ‘Product’? Products Liability Implications for AI-Based Products
April 10th 2025As the physical products we use evolve to become increasingly complex, traditional products liability frameworks may not always fit to provide remedies for harm that can result from using novel product types.
